The recently concluded session had traders exchanging Clovis Oncology, Inc. (NASDAQ:CLVS) low level. Roughly 0.94 million shares changed hands compared to the three-month volume average 1.66 million shares. The first trade took place at $84.23 and the stock went down -1.05% to attain the closing price of $83.5.Clovis Oncology, Inc. (CLVS) Analyst Opinion
Clovis Oncology, Inc. has a consensus outperform rating from 13 Wall Street analysts, and the number of shares currently sold short amount to at least 16.76% of shares outstanding. The stock spiked 24.31% last month and is up 87.98 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover CLVS having a buy-equivalent rating. Analysts have placed a $93.73 price target on Clovis Oncology, Inc., suggesting a 12.25% gain from recent close. It’s currently trading about -16.04% below its 52-week high.Clovis Oncology, Inc. Earnings Surprise
Clovis Oncology, Inc. (CLVS) surprised the stock market in its last reported earnings when it earned -$1.29 a piece versus the consensus-estimated -$2.13. Its revenue totaled $13.31 million up 88.79% from the previous quarter.Clovis Oncology, Inc. (NASDAQ:CLVS) Intraday View
This stock (CLVS) is ahead of its 52-week low with 227.45%. Its last month’s stock price volatility remained 3.82% which for the week stands at 5.15%. The share price has moved forward from its 20 days moving average, trading at a distance of 8.92% and stays 10.42% away from its 50 days moving average. Over the last five days, shares have managed 3.91% gains and now is up 25.14% since hitting its 200-day moving average of $70.59. Clovis Oncology, Inc. (CLVS) has made its way to a 12-month gain of 183.92%.
Turning to Transocean Ltd. (NYSE:RIG), its shares were trading at $10.51 a gain of $0.2, on the trading floor. So far, analysts are sticking with their bearish recommendations with the consensus call at 3. Transocean Ltd. has 1 buy ratings, 15 holds and 1 sells even after the stock tumbled -36.91% from its high of $16.66 to a $4.11 billion market value through last close.Transocean Ltd. (RIG) Consensus Price Target
The company’s consensus rating on Reuter’s scale slipped from 3.09 to 2.94 during a month. Analysts set a 12-month price target of $11 a share. The target implies a 4.66% spike from where the shares are currently trading. Also, the current price highlights a discount of 99.81% to analysts’ high consensus price target.Transocean Ltd. (NYSE:RIG) Intraday Trading
The counter witnessed a trading volume of 13.48 million shares versus an average volume of 16.96 million shares during last trading session. Its last month’s stock price volatility remained 3.06% which for the week approaches 4.04%. It has the $7.2 52-week low. The stock recovered 45.97% since its low point and has performed -28.7% year-to-date.